Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer

Vincenzo Serretta, Michele Battaglia, Paolo Verze, Estevao Lima, Riccardo Autorino, Matteo Ferro, Riccardo Schiavina, Gennaro Musi, Gilberto L. Almeida, Marco Borghesi, Gian Maria Busetto, Marco Borghesi, Giuseppe Ucciero, Mihai Dorin Vartolomei, Antonio Cioffi, Nicolae Crisan, Ettore De Berardinis, Rodolfo Hurle, Giorgio I. Russo, Chiara ScafuroAbdal Rahman Abu Farhan, Marco Borghesi, Francesco Cantiello, Daniela Terracciano, Sisto Perdonà, Ottavio De Cobelli, Deliu Victor Matei, Pierluigi Bove, Shahrokh F. Shariat, Savino M. Di Stasi, Giuseppe Morgia, Vincenzo Mirone, Rocco Damiano, Michele Battaglia, Giuseppe Lucarelli, Paolo Verze

Risultato della ricerca: Articlepeer review

22 Citazioni (Scopus)

Abstract

In this study, we defined a risk score (the SIM score) based on the measurement of routine systemic inflammatory markers. This score can identify patients with high-grade bladder cancer not invading the muscular layer who are more likely to suffer from tumor recurrence and progression. Therefore, the score could be used to select patients who might benefit from early bladder removal.
Lingua originaleEnglish
pagine (da-a)403-410
Numero di pagine8
RivistaEuropean urology oncology
Volume1
Stato di pubblicazionePublished - 2018

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2746???
  • ???subjectarea.asjc.2700.2730???
  • ???subjectarea.asjc.2700.2741???
  • ???subjectarea.asjc.2700.2748???

Fingerprint

Entra nei temi di ricerca di 'Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer'. Insieme formano una fingerprint unica.

Cita questo